Breast Cancer Chemo Timing Doesn't Affect Outcome
627878
WEDNESDAY, Feb. 2 (HealthDayNews) -- The timing of systemic chemotherapy in patients with breast cancer does not affect patient survival or disease progression, say researchers reporting in the Feb. 2 issue of the Journal of the National Cancer Institute.
114573
Group therapy doesn&#39;t improve survival for women with early-stage breast cancer, says a study in the Sept. 27 online issue of the Journal of Clinical Oncology.
203465
Gene mutations linked to breast cancer may pose less danger than previously believed, a new study shows.
476160
FRIDAY, Jan. 4 (HealthDay News) -- Early breast cancer tumors that have not yet spread contain cells with a predisposition to migrate to new tissue, a new study finds.
36689
Women who develop breast cancer are no more likely to have aggressive or advanced tumors if they are cigarette smokers than if they do not smoke, researchers said on Sunday.
562146
In women who&#39;ve been treated for breast cancer, use of the drug tamoxifen can help prevent recurrence of the disease. Now, new research indicates that the
453654
Women who have breast cancer detected by a mammogram run less risk of having cancer elsewhere in the body over the next 10 years than women whose tumors are discovered by other means, according to a new study.
449004
MONDAY, Oct. 29 (HealthDay News) -- It may be unhealthy in many other ways, but smoking does not appear to raise the odds that a woman with breast cancer will have more aggressive or later-stage malignancy at the time of diagnosis, researchers report.
704929
New research suggests that implants used for breast reconstruction after cancer surgery do not raise a woman's long-term risk of dying from breast cancer or other causes.
63325
Radiation treatments routinely given after surgery to remove small breast tumors may not be necessary for women over age 70 if they are taking the cancer drug tamoxifen.
466845
Women who seek support in coping with early-stage breast cancer through group counseling sessions don&#39;t appear to improve their odds of surviving the disease, new research indicates.
725892
NEW YORK  - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy.
193007
NEW YORK  - Women who seek support in  coping with early-stage breast cancer through group counseling  sessions don't appear to improve their odds of surviving the  disease, new research indicates.
225537
Having reconstructive surgery does not reduce the life expectancy of women with breast cancer, a study shows.
312982
MONDAY, July 23 (HealthDay News) -- A newer generation of breast cancer medications added months to the lives of patients with the most advanced form of the disease, according to the first study of its kind.
250736
WEDNESDAY, Dec. 26 (HealthDay News)-- Chemotherapy drugs known as anthracyclines help boost survival for women with HER2-positive breast cancer who have undergone surgery, but they may not offer any survival benefit for those with HER2-negative tumors.
600076
NEW YORK  - In women who've been treated  for breast cancer, use of the drug tamoxifen can help prevent  recurrence of the disease. Now, new research indicates that the  drug works equally well in black and white women.